AVALON VENTURES MANAGEMENT, LLC
CIK 2026666 · View on SEC EDGAR ↗
- Portfolio value
- $14.2M
- Positions
- 2
- As of
- Sept. 30, 2025 Data as of Q3 2025
Portfolio value QoQ: -25.3% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 1.2
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q3 2025: 0.0% Est. buys $244,400 · sells $0
Median holding: 3.0 quarters Tracked Q4 2024–Q3 2025 · 100.0% still held
- New positions
- 0
- Increased
- 1
- Decreased
- 0
- Closed
- 0
On this page
Performance vs S&P 500
Annualized: -41.3% · S&P 500: +18.3%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Full portfolio 2 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| KLTR Kaltura, Inc. - Common Stock | $12,906,298 | 90.83% | 8,962,707 | $-5,108,743 | |||
| JANX Janux Therapeutics, Inc. - Common Stock | $1,302,652 | 9.17% | 53,300 | $302,422 | Up ×1 | ||
| No matches | |||||||